Investigators addressed the treatment of acute gout flares in the emergency department.
Aortic stenosis was found to worsen more frequently in patients with vs without gout.
Researchers studied serum CA72-4 expression in patients with gout, and verified the hypothesis that CA72-4 was a predictor of future flares in gouty arthritis.
Researchers sought to understand the unmet needs for patients and provide insight into achieving better treatment for gout.
Febuxostat well tolerated in dialysis-dependent patients with gout.
Avion Pharmaceuticals announced the launch of Gloperba (colchicine) oral solution for prophylaxis of gout flares in adults.
Allopurinol and febuxostat were found to be associated with a higher risk of hypersensitivity reactions when compared to colchicine, according to the results of a recently published population-based study.
The goal of this 6-month prospective observational study was to assess sensitivity to change of ultrasound structural gout lesions, as defined by the OMERACT ultrasound group, among patients with gout undergoing urate-lowering therapy.
Researchers assessed changes in the estimated glomerular filtration rate among patients with gout with moderate renal impairment, using a treat-to-target approach for gout.
Researchers determined the effect of serum urate-associated genetic variants on gout risk in individuals receiving diuretics vs those who were not.